You searched for "wellbeing"
Identifying life-threatening uveal melanoma: A directed application of general-purpose AI
Uveal melanoma (UM) is a rare but aggressive eye cancer, affecting approximately six people per million annually [1]. Uveal melanoma arises in three locations: the choroid, ciliary body, and iris. As the most common primary intraocular malignancy in adults, UM...My Top Five: Uses of artificial intelligence in ophthalmology
3 August 2023
| Bilal Khan
|
EYE - General
Artificial Intelligence (AI) has emerged as a prominent topic of discussion within the field of ophthalmology, captivating researchers and practitioners alike. Although recent attention has been drawn to the integration of AI in ophthalmology, it’s important to recognise that AI...
My Top Five: Apps for UK-based general ophthalmologists
1 October 2021
| Yarrow Scantling-Birch, Rajagopal Govindan, Hasan Naveed
|
EYE - General
The way we interact in society is changing as more of us are becoming ‘digital natives’: individuals who are in close contact to the internet and expect to integrate smart devices with our daily lives. This was stereotypically a term...
My Top Five: Debunking common myths in ophthalmology and vision care
29 August 2024
| Jaskaran Singh, Christopher Stewart
|
EYE - General
In the field of eye health, numerous misconceptions persist. Let’s examine five prevalent myths and uncover the truth behind them. Myth 1: Wearing glasses weakens your eyesight Origin: This myth likely originated from the observation that people often need stronger...
Enhancing ophthalmology training: Unleashing the power of simulation
2 August 2024
| Connor Henry-Blake, Emma Pearson, Muhammed Jawad
|
EYE - General
Ethical and practical barriers hinder early surgical experience in ophthalmology training [1], which is problematic when early-career trainees bring a higher risk of poor surgical outcomes and patient harm [2]. The European working time directive and the surgical backlog secondary...
The management of retinal vein occlusions: a summary
1 February 2015
| Amy-lee Shirodkar
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...
The eye without tears
1 June 2016
| Hector Bryson Chawla
|
EYE - General
The Art is long and Life is short. So goes the dispiriting tag in Latin and flung from day one and at regular intervals thereafter at idle medical students who, inevitably brainwashed, come by graduation to believe that the only...
Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies
1 October 2018
| Rod McNeil
|
EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
Paediatric ptosis
Manoj Parulekar and colleagues provide a comprehensive overview of the diagnosis, assessment and management of childhood ptosis. Blepharoptosis (commonly referred to as ptosis – Greek, πτῶσις, ‘to fall’) is a condition where the upper eyelid is in an abnormally low...Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...Broadening of treatment options for potentially blinding retinal conditions
2 August 2022
| Rod McNeil
|
EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
Effect of the COVID-19 Urgent Eyecare Service on patient referrals to general practitioners and Hospital Eye Service
28 April 2023
| Hafsa Amjad, Nicholas Rumney
|
EYE - General
The COVID-19 Urgent Eyecare Services (CUES) was developed to relieve the demands of hospital ophthalmology, aiming to allow patients to have remote consultations and be managed by community optometric practice. This was because access to Hospital Eye Service (HES) Ophthalmic...
